Submitted by Anonymous (not verified) on 27 November 2024 - 13:44
Human medicines European public assessment report (EPAR): Oslif Breezhaler, indacaterol, Date of authorisation: 29/11/2009, Revision: 18, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Oslif Breezhaler, indacaterol, Date of authorisation: 29/11/2009, Revision: 18, Status: Authorised